Chembio Stock Alpha and Beta Analysis

CEMI
 Stock
  

USD 1.03  0.07  6.36%   

This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Chembio Diagnostics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Chembio Diagnostics over a specified time horizon. Remember, high Chembio Diagnostics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation.
Continue to Chembio Diagnostics Backtesting, Chembio Diagnostics Valuation, Chembio Diagnostics Correlation, Chembio Diagnostics Hype Analysis, Chembio Diagnostics Volatility, Chembio Diagnostics History and analyze Chembio Diagnostics Performance.
  
Please note that although Chembio Diagnostics alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., DOW index.) So in this particular case, Chembio Diagnostics did 1.13  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Chembio Diagnostics stock's relative risk over its benchmark. Chembio Diagnostics has a beta of 0.92  . Let's try to break down what Chembio's beta means in this case. Chembio Diagnostics returns are very sensitive to returns on the market. As the market goes up or down, Chembio Diagnostics is expected to follow.
Chembio Diagnostics Enterprise Value is most likely to increase significantly in the upcoming years. The preceding year's Enterprise Value was reported at 24.17 Million. The current Tangible Asset Value is estimated to increase to about 75.8 M, while Enterprise Value over EBIT is projected to decrease to (1.08) .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.

Chembio Diagnostics Quarterly Book Value per Share

0.659

Chembio Diagnostics Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Chembio Diagnostics market risk premium is the additional return an investor will receive from holding Chembio Diagnostics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Chembio Diagnostics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Chembio Diagnostics' performance over market.
α1.13   β0.92
90 days against DJI

Chembio Diagnostics expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Chembio Diagnostics' Buy-and-hold return. Our buy-and-hold chart shows how Chembio Diagnostics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Chembio Diagnostics Market Price Analysis

Market price analysis indicators help investors to evaluate how Chembio Diagnostics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Chembio Diagnostics shares will generate the highest return on investment. By understating and applying Chembio Diagnostics stock market price indicators, traders can identify Chembio Diagnostics position entry and exit signals to maximize returns.

Chembio Diagnostics Return and Market Media

The median price of Chembio Diagnostics for the period between Wed, May 11, 2022 and Tue, Aug 9, 2022 is 0.68 with a coefficient of variation of 17.53. The daily time series for the period is distributed with a sample standard deviation of 0.12, arithmetic mean of 0.7, and mean deviation of 0.08. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Chembio Diagnostics Coverage Initiated at StockNews.com - De...05/20/2022
2
Acquisition by Tesolichtman Leslie of 41143 shares of Chembi...05/26/2022
3
Infectious Disease Diagnostics Market worth 33.1 billion by ...06/13/2022
4
Global HIV Diagnostics Test Market to Surpass US 8,487.17 Mi...06/21/2022
5
Acquisition by Tesolichtman Leslie of 82286 shares of Chembi...06/29/2022
6
EPS Estimate06/30/2022
7
Major Player in the Point-of-Care or Rapid Diagnostics Marke...07/14/2022
8
Chembio Diagnostics to Report Second Quarter 2022 Financial ...07/21/2022
9
EPS Reported08/04/2022

About Chembio Diagnostics Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all equity instruments such as Ford or other stocks, funds, and ETFs. Alpha measures the amount that position in Chembio Diagnostics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 (projected)
Long Term Debt to Equity0.520.56
Interest Coverage825.06890.19

Chembio Diagnostics Upcoming Company Events

As portrayed in its financial statements, the presentation of Chembio Diagnostics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Chembio Diagnostics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Chembio Diagnostics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Chembio Diagnostics. Please utilize our Beneish M Score to check the likelihood of Chembio Diagnostics' management manipulating its earnings.
Upcoming Quarterly Report10th of March 2022
Next Financial Report5th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End10th of March 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Build Portfolio with Chembio Diagnostics

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Continue to Chembio Diagnostics Backtesting, Chembio Diagnostics Valuation, Chembio Diagnostics Correlation, Chembio Diagnostics Hype Analysis, Chembio Diagnostics Volatility, Chembio Diagnostics History and analyze Chembio Diagnostics Performance. Note that the Chembio Diagnostics information on this page should be used as a complementary analysis to other Chembio Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Watchlist Optimization module to optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm.

Complementary Tools for Chembio Stock analysis

When running Chembio Diagnostics price analysis, check to measure Chembio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chembio Diagnostics is operating at the current time. Most of Chembio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Chembio Diagnostics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chembio Diagnostics' price. Additionally, you may evaluate how the addition of Chembio Diagnostics to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Chembio Diagnostics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Chembio Diagnostics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Chembio Diagnostics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...